Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2022-08-29 2022-08-19
Drug Identification Number 02268825 02268825
Brand name ANGELIQ ANGELIQ
Common or Proper name Drospirenone /Estradiol-17ß Drospirenone /Estradiol-17ß
Company Name BAYER INC BAYER INC
Ingredients ESTRADIOL DROSPIRENONE ESTRADIOL DROSPIRENONE
Strength(s) 1.0MG 1.0MG 1.0MG 1.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 28's 28's
ATC code G03FA G03FA
ATC description PROGESTOGENS AND ESTROGENS IN COMBINATION PROGESTOGENS AND ESTROGENS IN COMBINATION
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-08-22 2022-08-22
Actual start date 2022-08-24
Estimated end date 2022-08-30 2022-08-30
Actual end date 2022-08-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Supply constraints Supply constraints
Health Canada comments